Past medical conditions and K-ras mutations in pancreatic ductal adenocarcinoma: a hypothesis-generating study

被引:9
|
作者
Crous-Bou, Marta [1 ,2 ,3 ]
Porta, Miquel [1 ,2 ,3 ]
Morales, Eva [1 ]
Lopez, Tomas [1 ,3 ]
Carrato, Alfredo [4 ]
Puigdomenech, Elisa [1 ,2 ,3 ]
Real, Francisco X. [1 ,5 ,6 ]
机构
[1] Univ Autonoma Barcelona, Clin & Mol Epidemiol Canc Unit, IMIM, Barcelona 08003, Spain
[2] Univ Autonoma Barcelona, Fac Med, Barcelona 08003, Spain
[3] CIBERESP, Barcelona, Spain
[4] Univ Miguel Hernandez, Hosp Univ Elche, Alacant, Spain
[5] Ctr Nacl Invest Oncol, Madrid, Spain
[6] Univ Pompeu Fabra, Barcelona, Spain
关键词
Medical conditions; Diabetes mellitus; Pancreatitis; Peptic ulcer; Pancreatic ductal adenocarcinoma; Pancreatic neoplasms; Etiology; K-ras oncogene; RISK-FACTORS; LIFE-STYLE; CODON; 12; CANCER; HISTORY; INFLAMMATION; ASSOCIATION; P53; EPIDEMIOLOGY; METAANALYSIS;
D O I
10.1007/s10552-008-9267-x
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
In pancreatic ductal adenocarcinoma (PDA) evidence on the etiopathogenic role of past medical conditions in the occurrence and persistence of K-ras mutations is scant. Incident cases of PDA were interviewed face-to-face about past medical history and other factors. Logistic regression was used to compare PDA cases (n = 120) with wild-type and mutated K-ras tumors (case-case study). Patients with wild-type K-ras tumors were more likely to have a prior diagnosis of pancreatitis (Odds ratio [OR] = 6.11, p = 0.041). Diabetes mellitus (DM) was non-significantly more common among cases with a K-ras wild-type tumor, and the OR for DM of > 6 years of duration was 4.54 (p = 0.39). Patients with wild-type K-ras were significantly more likely to have had a surgically treated peptic ulcer (OR = 9.03, p = 0.027). The probability of having a K-ras wild-type tumor increased with the number of medical conditions (p for trend = 0.012); the corresponding OR for two or more medical conditions was 4.46 (95% CI: 1.37-14.50). Results raise the hypothesis that pancreatitis and possibly peptic ulcer might influence pancreatic carcinogenesis through pathways independent of K-ras mutation, perhaps related to growth factors or mediators of the inflammatory response. Large unselected studies should be conducted to refute or replicate our findings.
引用
收藏
页码:591 / 599
页数:9
相关论文
共 50 条
  • [31] Low correspondence between K-ras mutations in pancreatic cancer tissue and detection of K-ras mutations in circulating DNA
    Marchese, Rodolfo
    Muleti, Alessandra
    Pasqualetti, Patrizio
    Bucci, Barbara
    Stigliano, Antonio
    Brunetti, Ercole
    De Angelis, Monica
    Mazzoni, Gianluca
    Tocchi, Adriano
    Brozzetti, Stefania
    PANCREAS, 2006, 32 (02) : 171 - 177
  • [32] K-ras protooncogene mutations in feline pancreatic adenocarcinomas
    Mayr, B
    Schaffner, G
    Reifinger, M
    Loupal, G
    VETERINARY RECORD, 2003, 153 (15) : 468 - +
  • [33] Vav1 and mutant K-Ras synergize in the early development of pancreatic ductal adenocarcinoma in mice
    Salaymeh, Yaser
    Farago, Marganit
    Sebban, Shulamit
    Shalom, Batel
    Pikarsky, Eli
    Katzav, Shulamit
    LIFE SCIENCE ALLIANCE, 2020, 3 (05)
  • [34] p16 and K-ras gene mutations in the intraductal precursors of human pancreatic adenocarcinoma
    Moskaluk, CA
    Hruban, RH
    Kern, SE
    CANCER RESEARCH, 1997, 57 (11) : 2140 - 2143
  • [35] Prevalence of K-ras mutations in a cohort of 30 cases of pancreatic adenocarcinoma at the Johannesburg Academic Hospitals
    Ngwenya, S.
    Pather, S.
    Baker, G.
    Willem, P.
    Babb, C.
    Naidoo, S.
    Perner, Y.
    Hale, M.
    HISTOPATHOLOGY, 2012, 61 : 145 - 145
  • [36] K-ras mutations in tumour specimens and peripheral blood samples of Hungarian patients with pancreatic adenocarcinoma
    Nadasi, Edit
    Varjas, Timea
    Prantner, Ida
    Papp, Robert
    Nowrasteh, Ghodratollah
    Ember, Istvan
    Kelemen, Dezso
    EUROPEAN JOURNAL OF ONCOLOGY, 2011, 16 (03): : 129 - 138
  • [37] B-RAF and K-RAS mutations in prostatic adenocarcinoma
    Cho, NY
    Kim, BH
    Cho, YM
    Moon, KC
    Kang, GH
    MODERN PATHOLOGY, 2006, 19 : 133A - 133A
  • [38] B-RAF and K-RAS mutations in prostatic adenocarcinoma
    Cho, NY
    Kim, BH
    Cho, YM
    Moon, KC
    Kang, GH
    LABORATORY INVESTIGATION, 2006, 86 : 133A - 133A
  • [39] INCREASED PREVALENCE OF K-RAS ONCOGENE MUTATIONS IN LUNG ADENOCARCINOMA
    MILLS, NE
    FISHMAN, CL
    ROM, WN
    DUBIN, N
    JACOBSON, DR
    CANCER RESEARCH, 1995, 55 (07) : 1444 - 1447
  • [40] Analysis of K-ras oncogene mutations in chronic pancreatitis with ductal hyperplasia
    Rivera, JA
    Rall, CJN
    GraemeCook, F
    FernandezdelCastillo, C
    Shu, P
    Lakey, N
    Tepper, R
    Rattner, DW
    Warshaw, AL
    Rustgi, AK
    SURGERY, 1997, 121 (01) : 42 - 49